1. Germany Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
EuroEyes International Eye Clinic Limited

EuroEyes International Eye Clinic Limited

HHKEX:1846
2.29
HKD
+0.00
(-0.22%)
971.29MMarket Cap
Mar 31Next Earn
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
6.38
10.24
10.89
1.68
1.44
1.93
1.84
2.15
2.17
2.49
- -
Basic EPS, GAAP
0.41
2.37
0.97
-0.01
0.2
0.41
0.27
0.4
0.25
0.17
- -
Free Cash Flow per Basic Share
-0.39
1.33
3.87
0.14
0.12
0.7
0.46
0.31
0.36
0.46
- -
Dividend per Share
- -
- -
- -
- -
0.19
0.03
0.1
0.12
0.08
0.06
- -
Book Value per Share
2.29
5.54
6.43
2.45
2.9
3.05
3.04
3.41
3.37
3.91
3.91
Tangible Book Value per Share
1.95
5.11
6.06
2.42
2.86
3.02
2.38
2.48
2.49
2.66
2.66
Basic Weighted Avg Shares
317
317
317
257
329
328
332
332
330
320
320
Sales/Revenue/Turnover
2,025
3,251
3,457
430
474
633
610
714
716
796
- -
Operating Margin (%)
12.87
39.94
19.18
7.07
23.38
30.22
22.4
24.39
14.5
14.7
- -
Depreciation Expense
328
498
486
67
67
75
81
87
112
128
- -
Net Income, GAAP
129
754
308
-3
66
134
89
131
82
54
- -
Effective Tax Rate (%)
38.99
32.67
41.47
117.29
35.05
32.34
35.25
30.09
33.3
44.71
- -
Profit Margin (%)
6.38
23.18
8.92
-0.8
13.84
21.1
14.66
18.37
11.5
6.84
- -
Working Capital
-330
246
567
667
771
814
675
617
561
498
498
LT Debt
894
919
1,709
188
188
176
243
314
251
326
326
Total Equity
788
1,839
2,146
851
990
1,040
1,043
1,166
1,126
1,284
1,284
Return on Invested Capital (%)
- -
27.59
9.23
-0.18
6.15
10.13
6.41
9.21
5.13
4.02
- -
Return on Capital (%)
- -
28.62
8.01
-0.17
6.19
11.22
7.71
9.43
5.8
3.66
- -
Return on Common Equity (%)
- -
60.65
16.24
-0.24
7.45
13.64
8.86
12.21
7.39
4.65
- -

Capital Structure

HKD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
69
75
84
LT Borrowings
- -
- -
- -
LT Finance Leases
251
270
326
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
325
320
320
Market Capitalization
1,283
872
971

Working Capital

HKD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
714
815
777
Cash, Cash Equivalents & STI
653
742
696
Accounts Receivable, Net
5
14
14
Inventories
17
16
15
Total Current Liabilities
152
214
278
Payables & Accruals
- -
- -
- -
ST Debt
69
75
84
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
5.56%
14.1%
Free Cash Flow
- -
88.95%
26.14%
Net Income, GAAP
- -
9.24%
-33.83%
Sales/Revenue/Turnover
- -
11.69%
11.23%
Total Cash Common Dividend
- -
23.1%
-26.84%

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
714
2024
- -
- -
716
2025
- -
- -
796

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.4
2024
- -
- -
0.25
2025
- -
- -
0.17

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.12
2024
- -
- -
0.08
2025
- -
- -
0.06

Company Description

Company Profile APIChatGPT
CEO
Jørn Slot Jørgensen
Full Time Employees
404
Sector
Health services
Industry
Medical/Nursing services
Address
Valentinskamp 90 Hamburg CQ Germany 20355
IPO Date
Oct 15, 2019
Website
euroeyes.hk
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
EuroEyes International Eye Clinic Limited delivers specialized vision correction services across Germany, Denmark, the People's Republic of China, and the United Kingdom. The company offers a broad spectrum of advanced refractive procedures, including state-of-the-art laser surgeries such as the minimally invasive SMILE Pro (an evolution of ReLEx SMILE using the ZEISS Visumax 800 laser) and Femto-LASIK, which incorporates wavefront technology. Furthermore, it provides phakic intraocular lens (ICL) implantation, particularly for patients with high refractive errors or thin corneas, a field where EuroEyes holds a leading position in Europe. Lens exchange operations, featuring both monofocal and advanced trifocal/multifocal options, are also a core offering, with the company recognized globally for its high volume of ZEISS trifocal lens implantations over many consecutive years. Additional services include PRK/LASEK and ICRS implantation. These specialized treatments cater to a range of visual impairments, including myopia, high myopia, presbyopia, and cataracts. The clinic group serves affluent individuals; younger patients typically seek solutions for myopia, while those over 45 primarily pursue presbyopia or cataract correction. Beyond surgical interventions, the company manages eye treatment and laser eye centers, distributes pharmaceutical products, engages in the trade of ophthalmic equipment and lenses, and facilitates equipment rental and facility operations. Established in 1993, EuroEyes International Eye Clinic Limited maintains its headquarters in Hamburg, Germany.